Gefragt von: Matthew Francis
Fragesteller Allgemeines

Biogen Hcp Portal

Der Link der Biogen Hcp Portal-Seite ist unten angegeben. Seiten, die sich auf Biogen Hcp Portal beziehen, werden ebenfalls aufgelistet.

Zuletzt aktualisiert: 2021-04-14

7

Added by: Michael Pottinger

Erklärer

Biogen Discontinues Development of …

04.02.2021 · HCP Portal; Multimedia. Podcasts & Flash Briefings; COVID-19 Info. COVID-19 Updates; Search for: Biogen Discontinues Development of Cinpanemab. February 4, 2021 February 4, 2021. by Marisa Wexler. In News. Click here to subscribe to the Parkinson’s News Today Newsletter! 5 (5) Due to negative clinical trial findings, Biogen has discontinued the development of cinpanemab (BIIB054), an ...
Url: https://parkinsonsnewstoday.com/2021/02/04/biogen-announcement-discontinue-cinpanemab-parkinsons/
Biogen Discontinues Development of …

342,511

Monatliche Besuche

277,164

Alexa Rank

US

Beliebt in

Up

Service Status

Added by: Anne Whealy

Erklärer

Biogen Declines Early Access to Tofersen for …

31.03.2021 · HCP Portal; COVID-19 Info. COVID-19 Updates; Search for: Biogen Declines Early Access to Tofersen Until Pivotal Trial Ends. March 31, 2021 March 31 , 2021. by Marta Figueiredo PhD. In News. Click here to subscribe to the ALS News Today Newsletter! 4.6 (10) Biogen will not offer early access to tofersen, its experimental therapy for familial amyotrophic lateral sclerosis (ALS) caused by ...
Url: https://alsnewstoday.com/news-posts/2021/03/31/biogen-rejects-early-access-tofersen-familial-als-until-pivotal-trial-ends/
Biogen Declines Early Access to Tofersen for …

184,144

Monatliche Besuche

512,997

Alexa Rank

IN

Beliebt in

Up

Service Status

Added by: Carol Thomas

Erklärer

Tofersen (BIIB067 - Previously IONIS-SOD1Rx) …

HCP Portal; COVID-19 Info. COVID-19 Updates; Search for: Tofersen (BIIB067 – Previously IONIS-SOD1Rx) Home » Tofersen (BIIB067 – Previously IONIS-SOD1Rx) Click here to subscribe to the ALS News Today Newsletter! Tofersen (BIIB067) previously called IONIS-SOD1Rx is an investigational therapy to slow the progression of familial amyotrophic lateral sclerosis (ALS). The therapy was …
Url: https://alsnewstoday.com/ionis-sod1-rx-biib067/
Tofersen (BIIB067 - Previously IONIS-SOD1Rx) …

184,144

Monatliche Besuche

512,997

Alexa Rank

IN

Beliebt in

Up

Service Status

Added by: Janice Kalyniuk

Erklärer

Independent Healthcare Market Research | …

07.04.2021 · Client Portal; The Leading Independent Healthcare Research Team Smart Starts Here. Learn More . Vision. At Spherix, we are a hyper-focused market intelligence firm that leverages our own independent data and expertise to provide strategic guidance, so that you can make decisions with confidence. We specialize in select dermatology, gastroenterology, nephrology, neurology, and …
Url: https://www.spherixglobalinsights.com/
Independent Healthcare Market Research | …

24,530

Monatliche Besuche

3,789,854

Alexa Rank

UNKNOWN

Beliebt in

Up

Service Status

Added by: Rachel Mckay

Erklärer

Coming Soon: 30 Days of Parkinson’s

29.03.2021 · HCP Portal; Multimedia. Podcasts & Flash Briefings; COVID-19 Info. COVID-19 Updates; Search for: Coming Soon: 30 Days of Parkinson’s. March 29, 2021 March 29, 2021. by BNS Staff. In 30 Days of PAR. Click here to subscribe to the Parkinson’s News Today Newsletter! 4.9 (9) Parkinson’s News Today is excited to announce a new initiative called “30 Days of Parkinson’s,” in recognition ...
Url: https://parkinsonsnewstoday.com/2021/03/29/coming-soon-30-days-of-parkinsons/
Coming Soon: 30 Days of Parkinson’s

342,511

Monatliche Besuche

277,164

Alexa Rank

US

Beliebt in

Up

Service Status

Added by: Margaret Nolan

Erklärer

European Commission OKs Subcutaneous …

08.04.2021 · The European Commission has approved under-the-skin injection of the relapsing-remitting multiple sclerosis treatment Tysabri (natalizumab).
Url: https://multiplesclerosisnewstoday.com/news-posts/2021/04/08/european-commission-new-subcutaneous-administration-tysabri-natalizumab-treatment-relapsing-remitting-multiple-sclerosis/
European Commission OKs Subcutaneous …

340,158

Monatliche Besuche

279,066

Alexa Rank

US

Beliebt in

Up

Service Status

Added by: NEXT Pharma Summit

Erklärer

How To Build A Game-changing HCP Portal (For You And Your Customers)

How To Build A Game-changing HCP Portal (For You And Your Customers)

Added by: Biogen

Erklärer

We are pioneers in neuroscience. We are Biogen.

We are pioneers in neuroscience. We are Biogen.

Added by: Lemelson MIT

Erklärer

Biogen Community Lab Speaker Series with LMIT: March 17, 2021

Biogen Community Lab Speaker Series with LMIT: March 17, 2021

Added by: Biogen

Erklärer

Biogen -- Caring Deeply, Changing Lives.

Biogen -- Caring Deeply, Changing Lives.

Added by: Biogen

Erklärer

Moving Biogen Forward

Moving Biogen Forward

Added by: Biogen

Erklärer

Interning at Biogen

Interning at Biogen

Added by: Biogen

Erklärer

Customer Excellence & Operations (CE&O) rotational program

Customer Excellence & Operations (CE&O) rotational program

Added by: PeopleDoc

Erklärer

Biogen's HR Transformation

Biogen's HR Transformation

Added by: Comparably

Erklärer

Working at Biogen - May 2018

Working at Biogen - May 2018

Added by: bredentgroup marketing

Erklärer

BioHPP: neue Dimension in der prothetischen Versorgung von Implantaten

BioHPP: neue Dimension in der prothetischen Versorgung von Implantaten
Ähnliche Fragen
Kürzlich besucht